Clinical Trials
26 trialsPIRe
Rigshospitalet, Denmark
EViDENCE-BT
University of Zurich
rTMS for Postoperative Brain Tumor Patients
Columbia University
A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors(CROWN)
Tianjin Medical University Cancer Institute and Hospital
Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma
Wake Forest University Health Sciences
Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors
Thomas Jefferson University
LOC-R01
Institut Curie
GK-LIVE
Sunnybrook Health Sciences Centre
STRONGER
The George Institute
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Virginia Commonwealth University
Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Stanford University
Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
H. Lee Moffitt Cancer Center and Research Institute
METAMORF
University of Aarhus
MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning
Memorial Sloan Kettering Cancer Center
A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
Wake Forest University Health Sciences
Tx-Treatment
Stanford University
NCGENES
University of North Carolina, Chapel Hill
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
H. Lee Moffitt Cancer Center and Research Institute
Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors
Virginia Commonwealth University
Virtual Reality-Based Exercise in Cancer Patients
University of Arizona
Depocyt® With Sorafenib in Neoplastic Meningitis
H. Lee Moffitt Cancer Center and Research Institute
A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Cyberknife Precision Radiation Delivery System for Tumors of the Spine
Stanford University
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
University of New Mexico
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute